Treatment with the vascular disruptive agent OXi4503 induces an immediate and widespread epithelial to mesenchymal transition in the surviving tumor-Reference-Cited by-同舟云学术

Treatment with the vascular disruptive agent OXi4503 induces an immediate and widespread epithelial to mesenchymal transition in the surviving tumor

Published:2013-08-18 Issue:5 Volume:2 Page:595-610
ISSN:2045-7634
Container-title:Cancer Medicine
language:en
Short-container-title:Cancer Med

Author:

Fifis Theodora¹,Nguyen Linh¹,Malcontenti‐Wilson Cathy¹,Chan Lie Sam¹,Nunes Costa Patricia Luiza¹,Daruwalla Jurstine¹,Nikfarjam Mehrdad¹,Muralidharan Vijayaragavan¹,Waltham Mark²,Thompson Erik W.²³,Christophi Christopher¹

Affiliation:

1. Department of Surgery University of Melbourne Austin Health Heidelberg Victoria 3084 Australia

2. St. Vincent's Institute of Medical Research Fitzroy Victoria 3065 Australia

3. Department of Surgery University of Melbourne St. Vincent's Hospital Fitzroy Victoria 3065 Australia

Publisher

Wiley

Subject

Cancer Research,Radiology Nuclear Medicine and imaging,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cam4.109

Reference46 articles.

1. Multifactorial nature of tumor drug resistance;Solyanik G. I.;Exp. Oncol.,2010

2. Modes of resistance to anti-angiogenic therapy

3. Support of a free radical mechanism for enhanced antitumor efficacy of the microtubule disruptor OXi4503

4. Disrupting tumour blood vessels

5. Spatial morphological and molecular differences within solid tumors may contribute to the failure of vascular disruptive agent treatments

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting vascular disrupting agent-treated tumor microenvironment with tissue-penetrating nanotherapy;Scientific Reports;2024-07-30

2. SAR131675, a VEGRF3 Inhibitor, Modulates the Immune Response and Reduces the Growth of Colorectal Cancer Liver Metastasis;Cancers;2022-05-31

3. Dynamic EMT: a multi‐tool for tumor progression;The EMBO Journal;2021-08-30

4. The influence of hypoxia and energy depletion on the response of endothelial cells to the vascular disrupting agent combretastatin A-4-phosphate;Scientific Reports;2020-06-18

5. The stilbene and dibenzo[b,f]oxepine derivatives as anticancer compounds;Biomedicine & Pharmacotherapy;2020-03